BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 35301610)

  • 1. Prognostic Significance of Primary Tumor-Infiltrating Lymphocytes in a Contemporary Melanoma Cohort.
    Straker RJ; Krupp K; Sharon CE; Thaler AS; Kelly NJ; Chu EY; Elder DE; Xu X; Miura JT; Karakousis GC
    Ann Surg Oncol; 2022 Aug; 29(8):5207-5216. PubMed ID: 35301610
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The prognostic significance of tumor-infiltrating lymphocytes for primary melanoma varies by sex.
    Sinnamon AJ; Sharon CE; Song Y; Neuwirth MG; Elder DE; Xu X; Chu EY; Ming ME; Fraker DL; Gimotty PA; Karakousis GC
    J Am Acad Dermatol; 2018 Aug; 79(2):245-251. PubMed ID: 29518458
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor-infiltrating lymphocytes predict sentinel lymph node positivity in patients with cutaneous melanoma.
    Taylor RC; Patel A; Panageas KS; Busam KJ; Brady MS
    J Clin Oncol; 2007 Mar; 25(7):869-75. PubMed ID: 17327608
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is the presence of tumor-infiltrating lymphocytes predictive of outcomes in patients with melanoma?
    Morrison SL; Han G; Elenwa F; Vetto JT; Fowler G; Leong SP; Kashani-Sabet M; Pockaj BA; Kosiorek HE; Zager JS; Sondak VK; Messina JL; Mozzillo N; Schneebaum S; Han D;
    Cancer; 2022 Apr; 128(7):1418-1428. PubMed ID: 35103302
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor-infiltrating lymphocyte grade is an independent predictor of sentinel lymph node status and survival in patients with cutaneous melanoma.
    Azimi F; Scolyer RA; Rumcheva P; Moncrieff M; Murali R; McCarthy SW; Saw RP; Thompson JF
    J Clin Oncol; 2012 Jul; 30(21):2678-83. PubMed ID: 22711850
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histological regression in melanoma: impact on sentinel lymph node status and survival.
    Aivazian K; Ahmed T; El Sharouni MA; Stretch JR; Saw RPM; Spillane AJ; Shannon KF; Ch'ng S; Nieweg OE; Thompson JF; Lo SN; Scolyer RA
    Mod Pathol; 2021 Nov; 34(11):1999-2008. PubMed ID: 34247192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor-infiltrating lymphocyte response in cutaneous melanoma in the elderly predicts clinical outcomes.
    Grotz TE; Vaince F; Hieken TJ
    Melanoma Res; 2013 Apr; 23(2):132-7. PubMed ID: 23344159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and histopathological risk factors to predict sentinel lymph node positivity, disease-free and overall survival in clinical stages I-II AJCC skin melanoma: outcome analysis from a single-institution prospectively collected database.
    Mandalà M; Imberti GL; Piazzalunga D; Belfiglio M; Labianca R; Barberis M; Marchesi L; Poletti P; Bonomi L; Novellino L; Di Biagio K; Milesi A; Guerra U; Tondini C
    Eur J Cancer; 2009 Sep; 45(14):2537-45. PubMed ID: 19553103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of Tumor-Infiltrating Lymphocytes on Overall Survival in Merkel Cell Carcinoma.
    Butala AA; Jain V; Reddy VK; Sebro RA; Song Y; Karakousis G; Mitchell TC; Lukens JN; Shabason JE
    Oncologist; 2021 Jan; 26(1):63-69. PubMed ID: 32886418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunologic heterogeneity of tumor-infiltrating lymphocyte composition in primary melanoma.
    Weiss SA; Han SW; Lui K; Tchack J; Shapiro R; Berman R; Zhong J; Krogsgaard M; Osman I; Darvishian F
    Hum Pathol; 2016 Nov; 57():116-125. PubMed ID: 27473267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessing the Prognostic Significance of Tumor-Infiltrating Lymphocytes in Patients With Melanoma Using Pathologic Features Identified by Natural Language Processing.
    Yang J; Lian JW; Chin YH; Wang L; Lian A; Murphy GF; Zhou L
    JAMA Netw Open; 2021 Sep; 4(9):e2126337. PubMed ID: 34550383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histopathologic regression in patients with primary cutaneous melanoma undergoing sentinel lymph node biopsy is associated with favorable survival and, after metastasis, with improved progression-free survival on immune checkpoint inhibitor therapy: A single-institutional cohort study.
    Wagner NB; Knierim SM; Luttermann F; Metzler G; Yazdi AS; Bauer J; Gassenmaier M; Forschner A; Leiter U; Amaral T; Garbe C; Eigentler TK; Forchhammer S; Flatz L
    J Am Acad Dermatol; 2024 Apr; 90(4):739-748. PubMed ID: 38043594
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High level of TILs is an independent predictor of negative sentinel lymph node in women but not in men.
    Fortes C; Mastroeni S; Caggiati A; Passarelli F; Ricci F; Michelozzi P
    Arch Dermatol Res; 2021 Jan; 313(1):57-61. PubMed ID: 32266533
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coexistence of regression and tumor infiltrating lymphocytes is associated with more favorable survival in melanoma.
    Tas F; Erturk K
    J Cancer Res Clin Oncol; 2021 Sep; 147(9):2721-2729. PubMed ID: 33611652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is There a Relationship Between TILs and Regression in Melanoma?
    Morrison S; Han G; Elenwa F; Vetto JT; Fowler G; Leong SP; Kashani-Sabet M; Pockaj B; Kosiorek HE; Zager JS; Messina JL; Mozzillo N; Schneebaum S; Han D;
    Ann Surg Oncol; 2022 May; 29(5):2854-2866. PubMed ID: 35064332
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor infiltrating lymphocytes in lymph node melanoma metastases: a histopathologic prognostic indicator and an expression of local immune response.
    Mihm MC; Clemente CG; Cascinelli N
    Lab Invest; 1996 Jan; 74(1):43-7. PubMed ID: 8569196
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic significance of acral lentiginous histologic type in T1 melanoma.
    Mejbel HA; Torres-Cabala CA; Milton DR; Ivan D; Feldmeyer L; Namikawa K; Nagarajan P; Tetzlaff MT; Curry JL; Ross MI; Hwu WJ; Prieto VG; Aung PP
    Mod Pathol; 2021 Mar; 34(3):572-583. PubMed ID: 32759976
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Prognostic Significance of Sentinel Lymph Node Status for Patients with Thick Melanoma.
    Bello DM; Han G; Jackson L; Bulloch K; Ariyan S; Narayan D; Rothberg BG; Han D
    Ann Surg Oncol; 2016 Dec; 23(Suppl 5):938-945. PubMed ID: 27527717
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The value of tumor infiltrating lymphocytes as prognostic factor for lymph node status and survival amongst patients with cutaneous malignant melanoma.
    Alexandru Gata V; Milan Kubelac P; Buiga R; Vlad IC; Valean D; Muntean MV; Morariu DS; Bonci EA; Irimie A; Dina C; Achimas Cadariu PA
    J BUON; 2020; 25(6):2700-2707. PubMed ID: 33455116
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor-Infiltrating Lymphocytes in Patients with Melanoma: Which Is Its Prognostic Value?
    Angeramo CA; Laxague F; Armella ED; Rodríguez Catán J; Vigovich FA; Mezzadri NA; Fernandez Vila JM
    Indian J Surg Oncol; 2021 Dec; 12(4):770-775. PubMed ID: 35110901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.